Literature DB >> 6086315

Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080.

R Brown, C J Marshall, S G Pennie, A Hall.   

Abstract

A full length N-ras gene has been cloned from both the human fibrosarcoma cell line HT1080 and from normal human DNA. N-ras isolated from HT1080 will efficiently induce morphological transformation of NIH/3T3 cells in a transfection assay, whereas N-ras isolated from normal human DNA has no effect on NIH/3T3 cells. The coding regions of the normal N-ras gene have been sequenced and the predicted amino acid sequence of the N-ras product is very similar to that of the c-Ha-ras1 and c-Ki-ras2 products. By making chimeric molecules between the two cloned genes the activating alteration in the HT1080 N-ras gene has been localised to a single base change that results in an amino acid alteration at position 61 of the p21 N-ras product.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086315      PMCID: PMC557516          DOI: 10.1002/j.1460-2075.1984.tb01970.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

1.  Lambdoid phages that simplify the recovery of in vitro recombinants.

Authors:  N E Murray; W J Brammar; K Murray
Journal:  Mol Gen Genet       Date:  1977-01-07

2.  Three different human tumor cell lines contain different oncogenes.

Authors:  M J Murray; B Z Shilo; C Shih; D Cowing; H W Hsu; R A Weinberg
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

3.  A bacteriophage lambda vector for cloning large DNA fragments made with several restriction enzymes.

Authors:  W A Loenen; W J Brammar
Journal:  Gene       Date:  1980-08       Impact factor: 3.688

4.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.

Authors:  E Santos; S R Tronick; S A Aaronson; S Pulciani; M Barbacid
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

5.  Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells.

Authors:  M Goldfarb; K Shimizu; M Perucho; M Wigler
Journal:  Nature       Date:  1982-04-01       Impact factor: 49.962

6.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Authors:  T Y Shih; A G Papageorge; P E Stokes; M O Weeks; E M Scolnick
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

8.  Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus.

Authors:  T Y Shih; M O Weeks; P Gruss; R Dhar; S Oroszlan; E M Scolnick
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

9.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.

Authors:  L F Parada; C J Tabin; C Shih; R A Weinberg
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

10.  Human-tumor-derived cell lines contain common and different transforming genes.

Authors:  M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

View more
  38 in total

1.  Regulation of collagen I gene expression by ras.

Authors:  J L Slack; M I Parker; V R Robinson; P Bornstein
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Changes in protein expression during melanoma differentiation determined by computer analysis of 2-D gels.

Authors:  D Easty; I R Hart; K Patel; C Seymour; M Yacoub; A Domscheit; S Gunther; W Postel; A Gorg; M J Dunn
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

3.  Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV.

Authors:  Michael J Metzger; A Dusty Miller
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

4.  Point mutation in codon 61 of N-RAS genes in human myeloma cell lines.

Authors:  M Sawada; S Shimizu; T Arai; S Konda; N Enomoto; T Date
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

5.  Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.

Authors:  P J Hurlin; V M Maher; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence.

Authors:  E B Jakobovits; U Schlokat; J L Vannice; R Derynck; A D Levinson
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

7.  Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

Authors:  R Plattner; M J Anderson; K Y Sato; C L Fasching; C J Der; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

8.  Multiple mechanisms of N-phosphonacetyl-L-aspartate resistance in human cell lines: carbamyl-P synthetase/aspartate transcarbamylase/dihydro-orotase gene amplification is frequent only when chromosome 2 is rearranged.

Authors:  K A Smith; O B Chernova; R P Groves; M B Stark; J L Martínez; J N Davidson; J M Trent; T E Patterson; A Agarwal; P Duncan; M L Agarwal; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

9.  Rac1 mediates STAT3 activation by autocrine IL-6.

Authors:  T R Faruqi; D Gomez; X R Bustelo; D Bar-Sagi; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

10.  Malignant transformation of murine fibroblasts by a human c-Ha-ras-1 oncogene does not require a functional epidermal growth factor receptor.

Authors:  I A McKay; P Malone; C J Marshall; A Hall
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.